MDS/MPN Overlap Syndromes and Myelofibrosis

August 6, 2018

Aplastic Anemia
MDS International Foundation

Video

Dr. Eric Padrone, a hematologist from H. Lee Moffit Cancer Center, discusses current thinking on MDS/MPN overlap disorders and myelofibrosis.

Dr. Eric Padrone, a hematologist from H. Lee Moffit Cancer Center, discusses current thinking on MDS/MPN overlap disorders and myelofibrosis. Topics include an overview of MDS/MPN overlap disorders and myelofibrosis, current treatment options, and what the future of treatment holds for patients.

Related Videos

How Gene and Cell Therapy Is Developing in Dermatology

Joyce Teng, MD, PhD, discusses how therapeutic advances in fields like epidermolysis bullosa should progress treatment discourse in other rare dermatoses.

The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD

Comparing New Therapies for Dystrophic Epidermolysis Bullosa

Reviewing 2023 with FDA Commissioner Robert M. Califf, MD

Dunia Hatabah, MD | Image Credit: HCPLive

Ricky Safer: What Clinicians Need to Know About PSC

Ryan T. Fischer, MD: Long-Term Odevixibat Benefit for Alagille Syndrome

Saeed Mohammad, MD: IBAT Inhibitors for Cholestatic Disease

Mercedes Martinez, MD: Treatment Strategies for Autoimmune Hepatitis

Related Content

FDA Issues CRL to Abeona for Potential RDEB Cell Therapy

FDA Issues CRL to Abeona for Potential RDEB Cell Therapy

April 23rd 2024

Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD

Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD

October 25th 2023

RESTORE: MCO-010 Achieves Significant Vision Restoration in Retinitis Pigmentosa | Image Credit: Credit: V2osk/Unsplash

RESTORE: MCO-010 Achieves Significant Vision Restoration in Retinitis Pigmentosa

Rare Disease Report Podcast: FDA Reviews Combination Therapy for Pompe Disease

Rare Disease Report Podcast: FDA Reviews Combination Therapy for Pompe Disease

October 28th 2022

Amy Paller, MD: Long-Term Outlook for EB, Ichthyosis and Netherton Syndrome Treatment

Amy Paller, MD: Long-Term Outlook for EB, Ichthyosis and Netherton Syndrome Treatment

Amy Paller, MD: What Pz-cel, B-VEC Each Bring to Recessive DEB

Amy Paller, MD: What Pz-cel, B-VEC Each Bring to Recessive DEB

Related Content

FDA Issues CRL to Abeona for Potential RDEB Cell Therapy

FDA Issues CRL to Abeona for Potential RDEB Cell Therapy

April 23rd 2024

Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD

Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD

October 25th 2023

RESTORE: MCO-010 Achieves Significant Vision Restoration in Retinitis Pigmentosa | Image Credit: Credit: V2osk/Unsplash

RESTORE: MCO-010 Achieves Significant Vision Restoration in Retinitis Pigmentosa

Rare Disease Report Podcast: FDA Reviews Combination Therapy for Pompe Disease

Rare Disease Report Podcast: FDA Reviews Combination Therapy for Pompe Disease

October 28th 2022

Amy Paller, MD: Long-Term Outlook for EB, Ichthyosis and Netherton Syndrome Treatment

Amy Paller, MD: Long-Term Outlook for EB, Ichthyosis and Netherton Syndrome Treatment

Amy Paller, MD: What Pz-cel, B-VEC Each Bring to Recessive DEB

Amy Paller, MD: What Pz-cel, B-VEC Each Bring to Recessive DEB

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.